The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, introduces Dailies Total1 Multifocal contact lenses for people with presbyopia. This innovative multifocal lens ...
The first and only monthly Water Gradient multifocal contact lens that feels like nothing – even at day 301 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven ...
JACKSONVILLE, Fla., June 23, 2025 /CNW/ -- Today, Johnson & Johnson, † a global leader in eye health, announced the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first and only ...
Johnson & Johnson is launching what it describes as the first and only daily disposable, multifocal and toric contact lens for people who have both astigmatism and presbyopia, where near-distance ...
The unique design of NaturalVue Multifocal offers intervention for multiple potential causes of myopic progression, and its availability as a daily disposable contact lens makes it ideal for use in ...
Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb has unveiled two new products intended to mitigate contact lens dryness: a daily disposable ...
Please provide your email address to receive an email when new articles are posted on . The kalifilcon A multifocal lens was easy to fit and provided clear visual outcomes. Investigators also reported ...
DENVER--(BUSINESS WIRE)--Visioneering Technologies Inc. (ASX: VTI), a technology-focused company dedicated to improving vision, today announced the availability of NaturalVue® (etafilcon A) Multifocal ...
Studies presented at #Academy25 reveal that ACUVUE OASYS MAX 1-Day for ASTIGMATISM outperformed Dailies Total1 ® for Astigmatism in patient reported outcomes related to vision and comfort. Research ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of TOTAL30 ® Multifocal in Canada, the first and only monthly Water Gradient multifocal ...
JACKSONVILLE, Fla., Oct. 7, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson*, a global leader in eye health, announced new data on the ACUVUE OASYS MAX 1-Day for ASTIGMATISM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback